renovascular hypertension naif alqarni بسم الله الرحمن الرحيم
Post on 22-Dec-2015
Embed Size (px)
- Slide 1
- RENOVASCULAR HYPERTENSION NAIF ALQARNI
- Slide 2
- PHYSIOLOGY OF R.A.A.S Angiotensinogen The source of all angiotensins. The liver is the primary site of synthesis, which is not stored but secreted directly after production. Several hormones stimulate angiotensinogen synthesis by the liver, including estrogens, glucocorticoids.Stress-full stimuli. Feedback control through AII and renin.
- Slide 3
- Renin The kidney is the major site of renin production. mechanisms affect the secretion AMacula Densa Mechanism Reduction of salt delivery stimulates renin secretion and vice versa BBaroreceptor Mechanism Diminished cell stretch as a result of renal hypoperfusion,hyperpolarizes the juxtaglomerular cells.
- Slide 4
- CNeural Mechanism -adrenergic ; and Dopamine. DEndocrine and Paracrine Mechanisms Prostaglandin E 2 and I 2 EIntracellular Mechanisms Agents that increase cyclic AMP.
- Slide 5
- Angiotensin-Converting Enzyme pulmonary endothelial ACE is presumed to be the major site of ACE.
- Slide 6
- Angiotensin II Effect of Angiotensin II on Glomerular Circulation. Tubular Effects. Medullary Effects. Vascular Effects. Adrenal Effects. Central Nervous Effect. Gonadal Effect.
- Slide 7
- Angiotensin II Receptor Subtypes Angiotensin receptor subtypes, named AT1 and AT2. In the kidneys, AT1 receptors are located predominantly in the glomeruli and tubulointerstitium, whereas AT2 receptors are located in the large cortical blood vessels.
- Slide 8
- PATHOLOGY AND NATURAL HISTORY OF RVH
- Slide 9
- Atherosclerosis Approximately 70% of all renovascular lesions are caused by atherosclerosis. Atherosclerotic stenosis usually occurs in the proximal 2 cm of the renal artery. The lesion involves the intima of the artery and, in two thirds of the cases, arises as an eccentric plaque.
- Slide 10
- Slide 11
- Atherosclerosis Seen predominantly in males and usually in older age groups. progressive arterial obstruction occurs in 42% to 53% of patients with atherosclerotic renal artery disease, often within the first 2 years of radiographic follow-up.
- Slide 12
- Atherosclerosis The incidence of progression to complete renal artery occlusion in the most wide study has ranged from 9% to 16%, and this has occurred more often in arteries that initially showed high degrees of stenosis.
- Slide 13
- Atherosclerosis Atherosclerotic renal artery disease progresses in many patients and that loss of functioning renal parenchyma is a common sequela of such progression. And artery obstruction can eventuate in end- stage renal disease (ESRD).
- Slide 14
- PATHOLOGY AND NATURAL HISTORY OF RVH Fibrous dysplasia Intimal Fibroplasia Primary intimal fibroplasia occurs in children and in young adults and constitutes approximately 10% of the total number of fibrous lesions. characterized by a circumferential accumulation of collagen inside the internal elastic lamina.
- Slide 15
- PATHOLOGY AND NATURAL HISTORY OF RVH Fibrous dysplasia Medial Fibroplasia Medial fibroplasia is the most common of the fibrous lesions, constituting 75% to 80% of the total number. It tends to occur in women between the ages of 25 and 50 years and often involves both renal arteries.
- Slide 16
- PATHOLOGY AND NATURAL HISTORY OF RVH Fibrous dysplasia Perimedial Fibroplasia Perimedial fibroplasia occurs predominantly in young women between the ages of 15 and 30 years and has therefore been referred to, rather crudely, as girlie disease. It constitutes about 10% to 15% of the total number of fibrous lesions.
- Slide 17
- PATHOLOGY AND NATURAL HISTORY OF RVH Fibrous dysplasia Fibromuscular Hyperplasia Fibromuscular hyperplasia is an extremely rare disease, constituting only 2% to 3% of fibrous lesions, and tends to occur in children and young adults.
- Slide 18
- PATHOLOGY AND NATURAL HISTORY OF RVH Miscellaneous: Renal artery aneurysms, middle aortic syndrome, periarterial fibrosis, and post-traumatic intimal or medial disease. Variable in location and obstruction; occurs in diverse clinical settings.
- Slide 19
- PATHOPHYSIOLOGY OF RVH Two-Kidney, One-Clip Model ischemia of the clipped kidney RAAS is activated generalized vasoconstriction and systemic hypertension
- Slide 20
- PATHOPHYSIOLOGY OF RVH Two-Kidney, One-Clip Model contralateral kidney higher than normal perfusion pressure suppression of renin secretion excreting higher than normal levels of sodium and water
- Slide 21
- PATHOPHYSIOLOGY OF RVH One-Kidney, One-Clip Model solitary ischemic kidney secretes renin activating the RAAS and resulting in systemic hypertension No contralateral kidney No excretion of Na and water
- Slide 22
- Stages in the development of renovascular hypertension Acute stage Transitional stage Days to weeks, in solitary kidney No contralateral kidney no dauiresis and natuiresis hyper vlemia AII and hypervolemia maintain renal perfusion decrease renin level So, in this case hypertension depend on volume expansion.
- Slide 23
- So, In patients with renovascular disease, particularly those with bilateral RAS or those with a stenotic renal artery to a single kidney, ACE inhibitors or AII antagonist may cause a deterioration of renal function and azotemia.
- Slide 24
- Stages in the development of renovascular hypertension In nmormal contralateral kidney volume expansion is avoided renin levels remain high So, HTN is due to RAAS.
- Slide 25
- Stages in the development of renovascular hypertension Chronic stage If blood flow is restored during these first 2 stages and renal perfusion is reinstated, blood pressure soon returns to a normal level. If renal hypoperfusion persists and stage 3 is reached, restoration of renal blood flow may not normalize blood pressure, presumably because of secondary irreversible vascular or renal parenchymal disease.
- Slide 26
- ISCHEMIC NEPHROPATHY This is a clinical syndrome that occurs through different pathophysiologic mechanisms, is distinct from RVH, and can occur in the absence of elevated blood pressure. IN is the result of chronic hypoperfusion of the total functioning renal mass.
- Slide 27
- ISCHEMIC NEPHROPATHY Renal autoregulation fails to maintain the GFR when renal perfusion decreases below 70 to 80 mm Hg. This occurs when the luminal diameter of the renal artery is stenosed by more than 70% of the original size. At this point, the stenosis becomes hemodynamically significant, resulting in a gradual deterioration of the GFR with an accompanying rise in the serum creatinine level.
- Slide 28
- ISCHEMIC NEPHROPATHY This injury is not simply cell death related to a lack of oxygen and nutrients ? because; The oxygen demand of the kidney never exceeds the supply. kidney needs only about 10% of its blood flow to maintain its oxygen requirement. So, the cellular mechanisms by which a decrease in renal size and IN develop are not well understood.
- Slide 29
- ISCHEMIC NEPHROPATHY mechanisms play a role, including vascular mediators (endothelin, thromboxane, prostacyclin, and nitric oxide), calcium accumulation in or ATP depletion of the ischemic cells, production of oxygen free radicals, or disruption of cellular membrane polarity ( Textor, 1994 ).
- Slide 30
- ISCHEMIC NEPHROPATHY HISTOPATHOLOGY Tubular necrosis and atrophy. Glomeruli decrease in size with wrinkling of the glomerular tuft and thickening of Bowman's capsule. Localized or global glomerular sclerosis. Hypercellularity of the juxtaglomerular apparatus is commonly seen.
- Slide 31
- Slide 32
- CLINICAL FEATURES OF RENOVASCULAR HYPERTENSION Clinical Clues The onset of hypertension. A family history. Sudden onset and shorter duration. Hypertension that is difficult to control Malignant hypertension or hypertensive crises. Smoking.
- Slide 33
- CLINICAL FEATURES OF RENOVASCULAR HYPERTENSION Peripheral Plasma Renin Activity To diagnose overactivity of the RAAS. Antihypertensive medications should be discontinued for 2 weeks. Blood should be collected 4 hours after the patient's ambulation.
- Slide 34
- CLINICAL FEATURES OF RENOVASCULAR HYPERTENSION Peripheral Plasma Renin Activity Sensitivity of 80% Specificity 84%. 16% of patients with essential hypertension have elevated PRA, whereas up to 20% of patients with RVH have normal PRA. No anatomic information and has no value for diagnosing IN
- Slide 35
- CLINICAL FEATURES OF RENOVASCULAR HYPERTENSION Captopril Test Measurement of peripheral PRA before and after an oral dose of captopril. All diuretics and ACE inhibitors need to be discontinued for at least 1 week before the test. A normal- or high-salt diet is needed Blood should be drawn with the patient in the same position before and after captopril administration. An oral dose of 25 mg of captopril is used, and blood is drawn again 1 hour after the dose.
- Slide 36
- CLINICAL FEATURES OF RENOVASCULAR HYPERTENSION Captopril Test Positive when; postcaptopril PRA gr